The rising prevalence of type 2 diabetes and obesity, rising aging populations and lifestyle changes, development of new and improved formulations, such as oral and multi-agonist therapies, and the increasing awareness regarding dual benefits of GLP-1 analogues for glycemic control and weight loss are some of the factors driving the expansion of GLP-1 analogues market
Clinical Evidence on GLP-1 Weight Loss Results The STEP trials, conducted across 4 randomized controlled studies involving over 4,500 participants, demonstrated that semaglutide produces clinically significant weight reduction
These findings highlight the significant role of Sema in regulating glycolipid metabolism to mitigate cardiac remodeling
This not only helps to maintain the skins barrier function but also ensures that it remains supple and radiant
What Does "In Your System" Actually Mean for Researchers
JANUMET XR has not been studied in patients with a history of pancreatitis
